American International Group’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,909
| Closed | -$33.1K | – | 243 |
|
|
2024
Q1 | $33.1K | Sell |
1,909
-17
| -0.9% | -$295 | ﹤0.01% | 2862 |
|
|
2023
Q4 | $24.7K | Sell |
1,926
-7
| -0.4% | -$90 | ﹤0.01% | 2945 |
|
|
2023
Q3 | $71.5K | Buy |
1,933
+94
| +5% | +$3.48K | ﹤0.01% | 2694 |
|
|
2023
Q2 | $74K | Buy |
1,839
+19
| +1% | +$765 | ﹤0.01% | 2756 |
|
|
2023
Q1 | $132K | Buy |
1,820
+65
| +4% | +$4.71K | ﹤0.01% | 2329 |
|
|
2022
Q4 | $144K | Sell |
1,755
-6
| -0.3% | -$492 | ﹤0.01% | 2335 |
|
|
2022
Q3 | $166K | Buy |
1,761
+43
| +3% | +$4.05K | ﹤0.01% | 2263 |
|
|
2022
Q2 | $335K | Sell |
1,718
-8
| -0.5% | -$1.56K | ﹤0.01% | 1851 |
|
|
2022
Q1 | $401K | Sell |
1,726
-121
| -7% | -$28.1K | ﹤0.01% | 1849 |
|
|
2021
Q4 | $728K | Buy |
1,847
+38
| +2% | +$15K | ﹤0.01% | 1598 |
|
|
2021
Q3 | $810K | Sell |
1,809
-43
| -2% | -$19.3K | ﹤0.01% | 1550 |
|
|
2021
Q2 | $720 | Sell |
1,852
-17
| -0.9% | -$7 | ﹤0.01% | 1707 |
|
|
2021
Q1 | $671 | Buy |
1,869
+109
| +6% | +$39 | ﹤0.01% | 1678 |
|
|
2020
Q4 | $864 | Buy |
1,760
+29
| +2% | +$14 | ﹤0.01% | 1466 |
|
|
2020
Q3 | $561K | Buy |
1,731
+326
| +23% | +$106K | ﹤0.01% | 1536 |
|
|
2020
Q2 | $512K | Buy |
1,405
+186
| +15% | +$67.8K | ﹤0.01% | 1576 |
|
|
2020
Q1 | $259K | Sell |
1,219
-71
| -6% | -$15.1K | ﹤0.01% | 1764 |
|
|
2019
Q4 | $531K | Sell |
1,290
-10
| -0.8% | -$4.12K | ﹤0.01% | 1658 |
|
|
2019
Q3 | $459K | Buy |
1,300
+172
| +15% | +$60.7K | ﹤0.01% | 1714 |
|
|
2019
Q2 | $567K | Buy |
1,128
+58
| +5% | +$29.2K | ﹤0.01% | 1631 |
|
|
2019
Q1 | $1.06M | Sell |
1,070
-35
| -3% | -$34.8K | ﹤0.01% | 1288 |
|
|
2018
Q4 | $959K | Sell |
1,105
-8
| -0.7% | -$6.94K | ﹤0.01% | 1291 |
|
|
2018
Q3 | $1.15M | Buy |
1,113
+54
| +5% | +$55.8K | ﹤0.01% | 1354 |
|
|
2018
Q2 | $973K | Buy |
1,059
+218
| +26% | +$200K | ﹤0.01% | 1407 |
|
|
2018
Q1 | $820K | Buy |
841
+120
| +17% | +$117K | ﹤0.01% | 1387 |
|
|
2017
Q4 | $326K | Buy |
721
+38
| +6% | +$17.2K | ﹤0.01% | 2029 |
|
|
2017
Q3 | $283K | Buy |
683
+51
| +8% | +$21.1K | ﹤0.01% | 2084 |
|
|
2017
Q2 | $221K | Buy |
632
+60
| +10% | +$21K | ﹤0.01% | 2210 |
|
|
2017
Q1 | $294K | Buy |
572
+38
| +7% | +$19.5K | ﹤0.01% | 1937 |
|
|
2016
Q4 | $190K | Sell |
534
-2
| -0.4% | -$712 | ﹤0.01% | 2207 |
|
|
2016
Q3 | $286K | Buy |
536
+1
| +0.2% | +$534 | ﹤0.01% | 1941 |
|
|
2016
Q2 | $301K | Buy |
535
+125
| +30% | +$70.3K | ﹤0.01% | 1875 |
|
|
2016
Q1 | $196K | Buy |
410
+48
| +13% | +$22.9K | ﹤0.01% | 2806 |
|
|
2015
Q4 | $239K | Buy |
362
+2
| +0.6% | +$1.32K | ﹤0.01% | 2657 |
|
|
2015
Q3 | $283K | Hold |
360
| – | – | ﹤0.01% | 2494 |
|
|
2015
Q2 | $474K | Buy |
360
+215
| +148% | +$283K | ﹤0.01% | 2243 |
|
|
2015
Q1 | $150K | Hold |
145
| – | – | ﹤0.01% | 3212 |
|
|
2014
Q4 | $96.7K | Buy |
+145
| New | +$96.7K | ﹤0.01% | 3613 |
|